Triple
T14008625
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CoronaVac |
E337018
|
entity |
| Predicate | developer |
P73
|
FINISHED |
| Object | Sinovac |
E337018
|
NE FINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sinovac Context triple: [CoronaVac, developer, Sinovac]
-
A.
Sinovac
chosen
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
B.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
C.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
D.
Sinopharm BIBP COVID-19 vaccine
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine developed by the Beijing Institute of Biological Products and widely used globally, particularly in many low- and middle-income countries, to prevent COVID-19.
-
E.
Sputnik V COVID-19 vaccine
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d81c645c5c8190b1fd16a285a1b78a |
elicitation | completed |
| NER | batch_69de2ed44f90819099ad08c09c066b56 |
ner | completed |
| NED1 | batch_69fcb653fedc81908cdd0dde2d3f3329 |
ned_source_triple | completed |
Created at: April 9, 2026, 10:19 p.m.